Cell reports, 2019
Cancer discovery, 2019
Cancer cell, 2018
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.
Nature medicine, 2017
Proceedings of the National Academy of Sciences of the United States of America, 2017
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
Nature genetics, 2017
Cell reports, 2013
Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.
International journal of hematology, 2013
Nature chemical biology, 2011
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.